BetterLife Pharma delays annual shareholder meeting to Dec. 9, 2026
The annual shareholder meeting was moved to Dec. 9, 2026 from Oct. 14, 2026, reclassified to an annual general and special meeting for Nasdaq listing-required shareholder votes.
The annual shareholder meeting was moved to Dec. 9, 2026 from Oct. 14, 2026, reclassified to an annual general and special meeting for Nasdaq listing-required shareholder votes.